Results 221 to 230 of about 147,721 (313)

Timing, risk, and reality: early venous thromboembolism chemoprophylaxis in patients with TBI requiring operative intervention. [PDF]

Trauma Surg Acute Care Open
Dhillon NK.
europepmc   +1 more source

Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis

International Journal of Dermatology, EarlyView.
Chronic prurigo, including prurigo nodularis, is a chronic, often treatment‐refractory condition characterized by persistent pruritus and chronic scratch lesions. Advances in the understanding of its underlying pathophysiology have enabled the development of novel targeted therapies; however, management remains challenging due to the expanding range of
Simon M. Mueller, Helmut Beltraminelli, Wolf‐Henning Boehncke, Maximilian Böhm, Antonio Cozzio, Peter Häusermann, Ahmad Jalili, Antonios G. A. Kolios, Claudia Lang, Eva Loos, Christoph Schlapbach, Curdin Conrad   +11 more
wiley   +1 more source

Gut Microbiota Dysbiosis and Risk of Venous Thromboembolism: A Systematic Review. [PDF]

Microorganisms
Franco-Moreno A, de Ancos-Aracil CL, Martínez-Casa-Muñoz A, Torres-Macho J, Ruiz-Navío E, Bustamante-Fermosel A, Hornero-Vázquez M, Casado-Suela MÁ.   +7 more
europepmc   +1 more source

Geographical variability in dabigatran dosing within New Zealand

Internal Medicine Journal, EarlyView.
Abstract Dabigatran etexilate is an oral anticoagulant with increased risk of bleeding at high drug exposure. It is available in three capsule strengths (75, 110 and 150 mg). We analysed New Zealand dispensing data from 2019 to 2023 to compare use between health districts. Overall use was similar across districts.
Liam T. Berryman, Paul K. L. Chin, Lorna J. Pairman, Milan Sundermann, Matthew Doogue   +4 more
wiley   +1 more source

Risk of venous thromboembolism following human papillomavirus vaccination: a systematic review and meta-analysis. [PDF]

Gynecol Oncol Rep
Wang Y, Ao G, Hughes C.
europepmc   +1 more source

Maintenance intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: trends from an Australian tertiary centre

Internal Medicine Journal, EarlyView.
Abstract Background Chronic inflammatory demyelinating polyneuropathy (CIDP) is commonly treated with long‐term intravenous immunoglobulin (IVIg). Individual dosing requirements and duration of IVIg differ among patients, leading to significant heterogeneity in IVIg utilisation.
Kristina T. Pidd, Anthony Khoo
wiley   +1 more source

Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers. [PDF]

Eur Heart J
Roy DC, Wang TF, Mallick R, Burger D, Carrier M, Wells P, Hawken S.   +6 more
europepmc   +1 more source

Idiopathic Pulmonary Fibrosis update, comparing the Australasian Interstitial Lung Disease Registry to the Australian Idiopathic Pulmonary Fibrosis Registry

Internal Medicine Journal, EarlyView.
Abstract Background and aims Real‐world evaluation of clinical characteristics and treatment profile of patients with idiopathic pulmonary fibrosis (IPF) is needed to establish areas for improvement according to evidence‐based recommendations. This study evaluated the clinical characteristics and treatment profile of patients with IPF from the ...
Michelle Chee, Yet Hong Khor, Dan Jackson, Wendy Cooper, Jason D’Costa, Sally de Boer, Adrienne Edwards, Samantha Ellis, Eli Gabbay, Henry Gallagher, Ian Glaspole, Nicole Goh, Christopher Grainge, Peter Hopkins, Gregory Keir, Benjamin Kwan, John Mackintosh, Yuben Moodley, Irene Moore, Vidya Navaratnam, Chong Ong, Paul Reynolds, Karen Royals, Alan Teoh, Lauren Troy, Elizabeth Veitch, Margaret Wilsher, Jeremy Wrobel, Chris Zappala, Tamera Corte, Francis Thien, on behalf of the AILDR Steering Committee   +31 more
wiley   +1 more source

Letter to the Editor: High Risk of Venous Thromboembolism With Aspirin Prophylaxis After THA for High-riding Developmental Dysplasia of the Hip: A Retrospective, Comparative Study. [PDF]

Clin Orthop Relat Res
Qu S, Ding J, Song J, Jiang H.
europepmc   +1 more source

Zero‐Contrast Versus Contrast‐Guided Left Atrial Appendage Occlusion: A Comparative Analysis of Procedural and Long‐Term Outcomes

Journal of Cardiovascular Electrophysiology, EarlyView.
Zero‐contrast left atrial appendage occlusion yielded high procedural success and similar periprocedural adverse event rates compared to the contrast‐guided approach. At 45‐day follow‐up, successful LAA closure (defined as peri‐device leak ≤ 5 mm) and device‐related thrombus rates were similar.
Joe Demian, Andrew LaCombe, Arwa Younis, Mohamed Kanj, Walid I. Saliba, Pasquale Santangeli, Chadi Tabaja, Ioan Liuba, Bryan Baranowski, Tyler L. Taigen, Mandeep Bhargava, Oussama M. Wazni, Ayman A. Hussein   +12 more
wiley   +1 more source